Cardiology

Perioperative Beta-blockade: Will POISE Change Management?

September 10, 2008
Perioperative Beta-blockade: Will POISE Change Management?

Commentary by Michael LoCurcio MD, Michael Janjigian MD and Michael C Brabeck MD, FACP, NYU Division of General Internal Medicine

Cardiovascular complications continue to be a major cause of morbidity and mortality in the perioperative period. Although progress has been made in terms of risk stratification, an effective invasive or pharmacologic intervention that decreases this risk remains elusive. Well designed studies have shown that prophylactic invasive measures are not effective in decreasing this risk, leaving clinicians uncertain as to the best way to maximize the…

Read more »

Case Presentation: Acute Rheumatic Fever

August 29, 2008
Case Presentation: Acute Rheumatic Fever

Commentary by Bani Chander MD, PGY-3. and Ben Bergman MD, PGY-3

Please also see last week’s Class Act Post on the pathogenesis of Rheumatic Heart Disease 

A 34-year-old Hispanic male presents with the chief complaint of chest pain. The patient had been well until 10 days prior to admission, when he developed a severe sore throat accompanied by fever, rigors, and diffuse myalgias. There was no associated cough. Three days later, he visited his primary care physician at an outside facility and was prescribed…

Read more »

Class Act: Pathogenesis of Rheumatic Heart Disease

August 14, 2008
Class Act: Pathogenesis of Rheumatic Heart Disease

Class act is a feature of Clinical Correlations written by NYU 3rd and 4th year medical students. Prior to publication, each commentary is thoroughly reviewed for content by a faculty member.

Commentary by Matt Stein MS-4; Reviewed by Harold Horowitz MD, Professor, NYU Division of Infectious Diseases and Immunology

In general, acute rheumatic fever (ARF) is a delayed sequela of a group A streptococcus (GAS) pharyngeal infection. Following an initial throat infection, which is often either untreated or incompletely treated, there exists a latent period of two…

Read more »

Aspirin Use in the Primary Prevention of Cardiovascular Disease

June 25, 2008
Aspirin Use in the Primary Prevention of Cardiovascular Disease

Commentary by Daniel Frenkel, MD PGY-2 and Aleksandar Adzic, MD PGY-2 (in consultation with Greg Mints, MD Attending Physician, General Internal Medicine)

Case #1: A 47 year old man with no significant medical history, nonsmoker, and no family history of CAD. Blood pressure 124/72 Cholesterol 202, LDL 129, HDL 35, Triglycerides 190.
Case #2: A 36 year old man history of hypertension controlled with hydrochlorothiazide, smoker, with no family history of CAD. Blood pressure 134/72 Cholesterol 168, LDL 91, HDL 46, Triglycerides 155.

Would you…

Read more »

Meeting Perspectives: American College of Cardiology, Part 3

May 22, 2008
Meeting Perspectives: American College of Cardiology, Part 3

Commentary by Rob Donnino MD, NYU Division of Cardiology

The annual meeting of the ACC was held last month in Chicago. A good number of NYU faculty and fellows either presented at or attended the meetings. The cardiology fellows exhibited an impressive balance between exploring the Chicago nightlife and diligent attendance at the meetings. Several of the cardiology fellows presented some of the highlights of the ACC meeting at a recent journal club conference for the Cardiology Division. The third and final installment…

Read more »

Meeting Perspectives: American College of Cardiology, Part 2

May 14, 2008
Meeting Perspectives: American College of Cardiology, Part 2

Commentary by Rob Donnino MD, NYU Division of Cardiology

The annual meeting of the ACC was held last month in Chicago. A good number of NYU faculty and fellows either presented at or attended the meetings. The cardiology fellows exhibited an impressive balance between exploring the Chicago nightlife and diligent attendance at the meetings. Several of the cardiology fellows presented some of the highlights of the ACC meeting at a recent journal club conference for the Cardiology Division. They are being summarized in a…

Read more »

Meeting Perspectives: American College of Cardiology, Part 1

May 8, 2008
Meeting Perspectives: American College of Cardiology, Part 1

Commentary by Rob Donnino MD, NYU Division of Cardiology

The annual meeting of the ACC was held last month in Chicago. A good number of NYU faculty and fellows either presented at or attended the meetings. The cardiology fellows exhibited an impressive balance between exploring the Chicago nightlife and diligent attendance at the meetings. Several of the cardiology fellows presented some of the highlights of the ACC meeting at a recent journal club conference for the Cardiology Division. They will be summarized in…

Read more »

Noninvasive Cardiac Imaging: Coronary CT Angiography

March 26, 2008
Noninvasive Cardiac Imaging: Coronary CT Angiography

Commentary by Matt LaBarbera MD, PGY-3 and Rob Donnino, MD Instructor of Medicine, Division of Cardiology

Coronary CT angiography (CCTA) is a noninvasive imaging modality which can be used to evaluate the anatomy of the coronary arteries. Unlike coronary artery calcium scoring, which utilizes noncontrast CT to assess atherosclerotic disease burden, CCTA allows direct visualization of the coronary artery wall and lumen with the administration of intravenous contrast. The degree of coronary luminal stenosis can be reliably estimated, as can the presence or absence…

Read more »

Class Act: Are beta-blockers really contraindicated for patients with a diagnosis of reactive airway disease?

March 21, 2008
Class Act: Are beta-blockers really contraindicated for patients with a diagnosis of reactive airway disease?

Commentary by Katherine Khvilivitzky, NYU Medical Student

Class act is a feature of Clinical Correlations written by NYU 3rd and 4th year medical students. These posts focus on evidenced based answers to clinical questions related to patients seen by our students in the clinics or on the wards. Prior to publication, each commentary is thoroughly reviewed for content by a faculty member.

In the past, reactive airway disease was considered to be a contraindication to administration of all beta-blockers including ophthalmic preparations.…

Read more »

Meeting Perspectives: American Heart Association Scientific Sessions 2007- Report from the cardiology fellows

January 31, 2008
Meeting Perspectives: American Heart Association Scientific Sessions 2007- Report from the cardiology fellows

Commentary By: Steven Sedlis, MD Associate Professor of Medicine, Chief, Division of Cardiology Manhattan Veterans Administration Medical Center

This year’s AHA meeting was held in November in Orlando Florida. The cardiology fellows were not overly distracted by the attractions at Disneyworld – the social event of the week, cocktails in the lobby of the Rosen Centre Hotel with Glenn Fishman, Barry Rosenzweig, Jennifer Mieres and me was not much of a distraction either – so the fellows were able to concentrate…

Read more »

Breaking News: A Disappointment for Zetia

January 15, 2008
Breaking News: A Disappointment for Zetia

Commentary by Alana Choy-Shan MD, NYU Chief Resident

The highly anticipated results of the ENHANCE trial will likely be presented at the American College of Cardiology meeting in March, but the preliminary results already have everyone talking. ENHANCE was a multinational, double-blind randomized controlled trial sponsored by Merck and Schering-Plough (the manufacturers of the combination ezetimibe/simvastatin pill). A total of 720 patients who were heterozygotes for Familial Hypercholesterolemia were randomized to treatment with either ezetimibe/simvastatin 10/80mg or simvastatin 80mg. The primary endpoint was change in…

Read more »

Evaluation of Asymptomatic Wolff-Parkinson-White EKG Morphology

January 3, 2008
Evaluation of Asymptomatic Wolff-Parkinson-White EKG Morphology

Commentary by David Steckman MD, PGY-2 and William Slater MD, Associate Professor of Medicine, Division of Cardiology

Case: A 42 year-old man presents to clinic for routine follow-up. He is found to be hypertensive for the second consecutive clinic appointment. On routine EKG, you find a shortened PR interval and what looks to be a delta wave in V1-V3. The patient does not report any history of syncope, chest pain, palpitations or shortness of breath. In addition to treating his hypertension, what…

Read more »